Kemobotin (Carboplatin)
Model: Liquid Injection (in vial)
Category: Pharmaceutical
Exhibitor: CKD OTTO PHARMACEUTICALS
Booth No: M625
Characteristic
Strength : 150 mg & 450 mg
Dosage form : Liquid Injection
Indication: Advanced ovarian carcinoma, SCLC, squamous cell carcinoma of the head and neck, advanced transitional cell carcinoma of the bladder, significant responses have been observed when KEMOBOTIN® employed in the treatment of carcinoma of the cervix.
KEMOBOTIN® is frequently used in combination with other chemotherapeutic agent in various indications, such as with paclitaxel in first line therapy of ovarian carcinoma and non small cell lung cancer.
Storage Condition :
Store 2-8°C, protect from direct sunlight, do not freeze.
Other Products
Products you may be interested in
Highest Rated Products